KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Other financing activities (2016 - 2025)

Charles River Laboratories International has reported Other financing activities over the past 16 years, most recently at -$1.3 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 70.61% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$14.0 million, up 55.4%, while the annual FY2025 figure was -$14.0 million, 55.4% up from the prior year.
  • Other financing activities for Q4 2025 was -$1.3 million at Charles River Laboratories International, up from -$6.2 million in the prior quarter.
  • Over five years, Other financing activities peaked at $40.6 million in Q3 2021 and troughed at -$15.5 million in Q2 2022.
  • A 5-year average of -$1.3 million and a median of -$2.3 million in 2021 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: tumbled 85750.0% in 2022 and later surged 70.61% in 2025.
  • Year by year, Other financing activities stood at $2000.0 in 2021, then tumbled by 85750.0% to -$1.7 million in 2022, then plummeted by 141.97% to -$4.1 million in 2023, then fell by 9.58% to -$4.5 million in 2024, then surged by 70.61% to -$1.3 million in 2025.
  • Business Quant data shows Other financing activities for CRL at -$1.3 million in Q4 2025, -$6.2 million in Q3 2025, and -$6.5 million in Q2 2025.